![]() ![]() Zhang Y, Nguyen L, Lu CM, Wang E, Lauw MIS, Ball S, Dong N, Moscinski L, Chan O, Yun S, Sallman D, Sokol L, Shah B, Knepper T, Lancet J, Komrokji R, Padron E, Kuykendall A, Zhang L. ![]() Integrative molecular subtypes of acute myeloid leukemia. Mo Q, Yun S, Sallman DA, Vincelette ND, Peng G, Zhang L, Lancet JE, Padron E.Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma. Chavez JC, Foss FM, William BM, Brammer JE, Smith SM, Prica A, Zain JM, Tuscano JM, Shah H, Mehta-Shah N, Ramakrishnan Geethakumari PR, Wang BX, Zantinge S, Wang L, Zhang L, Boutrin A, Zhao W, Cheng L, Standifer N, Hewitt L, Enowtambong E, Shao W, Sharma S, Carlesso G, Moscow JA, Siu LL.Fujian College of Traditional Chinese Medicine - MD.University of Louisville - Anatomic and Clinical Pathology.Cedars Sinai Medical Center - Hematopathology.MD Anderson Cancer Center - Surgical Oncology and Experimental Therapeutics.Anatomic Pathology & Clinical Pathology - Pathology-Hematology.She has also been involved in editions of books and contributed >10 book chapters to expert edited books in the field. She has also been highly productive in publishing, and has gained an international reputation, being asked to present diagnostically challenging cases at international workshops. Several fellows she mentored have received awards issued by institution or national society, e.g., AOA. She is an excellent mentor and is sought by fellows and residents for clinical research activities and awarded outstanding clinical faculty by USF in 2013. She has been the Director of the Hematopathology fellowship program and has successfully overseen extended ACGME accreditation and the successful matriculation of each of our fellows. She currently has effort as an investigator on the NIHBI National MDS Study, where she oversees the national MDS Tissue Repository and aim to explore potential mechanisms of MDS and its related precursor neoplasms. In addition, her experts in diagnosis of myelodysplastic syndromes as well as other myeloid neoplasms made her grow and become one of the key faculty members in multiple phase I-III clinical trials during the past years. Zhang is an outstanding and dedicated clinician educator who continues to take an active role in clinical translational research, utilizing her skills as a hematopathologist along with her knowledge of immunohistochemistry and molecular diagnostics to bring value to both basic science investigations and clinical trials, which were evident by over 20 translational research projects that she proposed (as principle investigator) or has been involved (as co-PI), of which several are industry, state or nationally sponsored. During the first 4-5 years, she has exceeded the pre-set goals for clinical service, education and research and was appointed program director of the ACGME accredited hematopathology fellowship in 2011 and successfully promoted to the rank of Associate Member with Tenure in 2013. Labs/LabCorp) in Irvine, California for one year, and came to Moffitt in June 2008 as an Assistant Member. She initially took a position as a Medical Associate Director in a commercial laboratory (U.S. She then completed a residency in pathology and clinical medicine at the University of Louisville, Kentucky in 2005 followed by a two-year fellowship in hematopathology at Cedars-Sinai Medical Center in Los Angeles, California. During working in the well-known cancer institute (1994-2001) she gained a great deal of research experience in cancer biology, immunology and therapeutic experiences. When she arrived in the United States in 1994 she worked as a Postdoctoral Fellow and Research Associate at MD Anderson Cancer Center. Ling Zhang obtained her MD and MS degree and completed her residency and fellowship in China. Ling Zhang is an Associate Member in the Department of Hematopathology and Laboratory Medicine, Director of the Hematopathology Fellowship Program, and Associate Professor, USF Oncologic Sciences. Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphomaĭr. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |